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Abstract
Background
Alternatively activated (M2) macrophages are phenotypically characterized by the expres-
sion of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and
mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-
fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloprotei-
nase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-
fibrotic effects through the interaction with its receptors (ETA and ETB). The study investi-
gated the possible role of ET-1 in inducing the transition from cultured human macrophages
into M2 cells.
Methods
Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macro-
phages) with phorbol myristate acetate and subsequently maintained in growth medium
(M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2
inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte
(PBM)-derived macrophages obtained from healthy subjects, were maintained in growth
medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived
macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for
1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163,
TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real
time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and mac-
rophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was
investigated by gel zymography.
Results
ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206,
CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-
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derived macrophages compared to M0-controls and untreated cells. In cultured PBM-
derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to
untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both
cultured cell types.
Conclusion
ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process appar-
ently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in
those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic
sclerosis but also type 2 diabetes.
Introduction
Macrophages are key mediators of innate and adaptive immunity and they contribute to
homeostasis and tissue remodelling [1–3]. Local microenvironment drives macrophages to
acquire distinct functional and morphological properties and to polarize into classically acti-
vated (M1) or alternatively activated (M2) macrophages [3,4]. The M1 macrophages show a
pro-inflammatory phenotype, contributing to the intensive inflammation and tissue damage
or even predisposing to neoplastic transformation [4,5]. The M2 macrophages are involved in
wound healing by their anti-inflammatory properties [1–4]. Recently, M2 macrophages were
found to show a pro-fibrotic phenotype being able to induce fibrosis as well as exacerbate the
allergic process [4,5]. Although these macrophage subsets express distinct and specific pheno-
type markers, they are considered extremes of a continuum of functional states [3,6].
The M2 macrophages are activated by T-helper-2 cytokines (i.e. IL-4 and IL-13) and they
are characterized by the expression of specific phenotype markers, primarily scavenger recep-
tors-1 class A (CD204), mannose receptor-1 (CD206) and hemoglobin scavenger receptor
(CD163) [1,4]. These macrophages are also characterized by the production of specific cyto-
kines and chemokines, such as interleukin-10 (IL-10) and macrophage derived chemokine
(MDC or CCL-22), pro-fibrotic metalloproteases (i.e. MMP-9) and transforming growth fac-
tor-beta1 (TGFbeta1) [1,3]. The release of these molecules contributes to myofibroblast activa-
tion and the deposition of extracellular matrix components [2,7,8].
Recently, CD14brightCD204+/CD163+M2 macrophages were shown to be increased in the
peripheral blood and affected skin of systemic sclerosis (SSc) patients, thus indicating their
possible role in the pathogenesis of the disease, as well as in the development of dermal fibrosis
[9,10].
Endothelin-1 (ET-1) is a pro-fibrotic molecule mainly secreted by endothelial cells and its
plasma levels are highly increased in patients affected by SSc and type 2 diabetes, contributing
to the fibrotic process [11,12]. ET-1 exerts pro-fibrotic effects through the binding to its recep-
tors (ETA and ETB), which are expressed on several cell types including endothelial cells, fibro-
blasts and macrophages [13–15].
Based on these observations, the aim of the study was to investigate the ability of ET-1 to
induce the transition of cultured human macrophages towards an M2 phenotype, evaluating
the expression of specific markers and the over-production of pro-fibrotic molecules. More-
over, the action of a dual ET receptor antagonist (ETA/BRA, bosentan) in contrasting the M2
phenotype induction mediated by ET-1 was also investigated.
Endothelin-1 Effects on Cultured Macrophages
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Materials and Methods
Cell Cultures and Treatments
Human monocyte cells (THP-1 cell line, 1x106 cells/mL, accession number ICLC HTL97014,
Cell bank Interlab Cell Line Collection, Genoa, Italy) were plated in cell culture dishes and
stimulated with phorbol myristate acetate (PMA, 50ng/mL, Sigma-Aldrich, Italy) for 4 hours
to induce their differentiation into macrophages (M0 macrophages), in accordance with sev-
eral in vitro studies [16–18]. Once differentiated, PMA was removed and some M0 macro-
phages were treated for 72 hours with ET-1 (100nM, Enzo Life Science, UK) or pre-treated for
1 hour with ETA/BRA (bosentan, 10
-5M, Actelion Pharmaceutics, Switzerland) before being
stimulated with ET-1. The lyophilized ET-1 molecule was solved in sterile distilled water. All
treatments were made in RPMI at 5% fetal bovine serum (FBS), 1% penicillin-streptomycin
and 1% L-glutamine (Euroclone, Italy). Cultured M0 macrophages maintained in RPMI at 5%
FBS were used as untreated control cells (M0-controls). Other cultured M0 macrophages were
treated for 72 hours with IL-4 (10ng/mL, BioVision, CA, USA), as an inducer of the M2 phe-
notype, thus representing a positive control of the M2 macrophage polarization [1–4,19]. Pre-
liminary time-dependent experiments about treating cultured M0 macrophages with ET-1 for
24, 48 and 72 hours were carried out in order to investigate its ability to induce the expression
of the M2 macrophage phenotype markers. Preliminary results showed that ET-1 induced the
expression of CD204, CD206 and CD163 after 48 and 72 hours, whereas no effects were
observed after 24 hours (S1 Fig).
Based on these preliminary data, the effects of ET-1 in inducing the expression of all the M2
macrophage markers tested were investigated at 72 hours on cultured M0 macrophages.
At the same time, human monocytes were isolated from the peripheral blood mononuclear
cells (PBMCs) of 6 voluntary healthy subjects (mean age 42±10 years) using Ficoll-density gra-
dient and a monocyte isolation kit (Miltenyi Biotech, Italy). Human monocytes were analysed
by Flow cytometry using an anti-CD14-PE-Vio770 antibody (clone TU¨K4, Miltenyi Biotech).
Once isolated, cells were plated into tissue culture dishes (1.5x106 cells/mL) and maintained
in RPMI at 10% of FBS for 24 hours. Some cultured human monocytes were treated for 3 and
6 days with either ET-1 (100nM) or IL-4 (10ng/mL) in order to induce their differentiation
into M2 macrophages. Other cultured cells were pre-treated for 1 hour with ETA/BRA (10
-5M)
and then stimulated with ET-1 for 3 and 6 days, in accordance with several in vitro studies
[20,21]. Cultured human monocytes maintained in RPMI at 10% of FBS were used as
untreated cells.
Six independent in vitro experiments were performed on both cultured cell types,
respectively.
Immunocytochemistry
THP-1 cells and human monocytes were treated as described in the “Cell cultures and treat-
ment” paragraph. At the end of treatments, cells were fixed in 2% paraphormaldeide and incu-
bated with primary antibodies to human CD68 (clone KP1, dilution 1:200, macrophage
marker), CD204 (clone E5, dilution 1:200) and CD206 (clone 6A598, dilution 1:150) (Santa
Cruz Biotechnology, CA, USA). Linked antibodies were detected by biotin-conjugated second-
ary antibody and subsequently with horseradish-peroxydase (HRP)-streptavidin complex
(Vector Laboratories, CA, USA). The 3,3’-diaminobenzidine was used to detect the expression
of the investigated proteins. In each experimental condition, the detection of protein expres-
sion was performed evaluating the same number of cells by light microscopy (magnification
40X) (Leica, UK).
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Western Blotting
Total proteins were isolated by NucleoSpin RNA/protein (Macherey-Nagel, Germany) and
quantified by the Bradford method. For every condition, 0.035mg of protein were separated by
electrophoresis on 4–16% tris-glycine gel and transferred onto Hybond-C-nitrocellulose mem-
brane (Life Technologies Ltd, UK).
After 1 hour in blocking solution -phosphate buffer saline (PBS) 1x, 0.1% triton-X and 5%
non-fat powdered milk-, membranes were incubated overnight at 4˚C with primary antibodies
anti-human CD204 (clone E5, dilution 1:150, Santa Cruz Biotechnology), CD206 (clone
2A6A10, dilution 1:500, Proteintech, USA), CD163 (clone GHI/61, dilution 1:100, Novus Bio-
logical, Littleton, USA) and TGFbeta1 (dilution 1:2,000, GeneTex, Texas, USA).
Membranes were subsequently incubated for 1 hour with secondary antibody (dilution
1:2,000 Cell Signaling Technology, MA, USA).
To confirm similar loading of gels and the efficiency in the electrophoretic transfer, mem-
branes were also incubated with primary HRP-conjugated antibody to human beta-actin
(clone C4, dilution 1:5,000 Santa Cruz Biotechnology).
Protein synthesis was analysed by enhanced chemiluminescence system (Luminata Cre-
scendo, Millipore, Germany) and the densitometric analysis was performed by UVITEC analy-
sis software (UVITEC, UK). In both cultured cell types, for each experimental condition, the
values of CD204, CD206, CD163 and TGFbeta1 synthesis were normalized to those of the cor-
responding beta-actin. The resulting values of each treatment were subsequently normalized
to that of M0-controls or untreated cells respectively (taken as unit value by definition), in
order to obtain the level of protein synthesis.
Quantitative Real Time Polymerase Chain Reaction (qRT-PCR)
Total RNA was extracted with NucleoSpin RNA/protein (Macherey-Nagel) and quantified by
nanodrop (Thermo Scientific, USA), which also evaluated RNA integrity, in accordance with
the manufacturer’s protocol. For each experimental condition, first-strand cDNA was synthe-
sized from 0.001mg of total RNA using QuantiTect Reverse Transcription Kit (Qiagen, Italy).
Primers for human CD204 (NM_002445), CD206 (NM_002438), CD163 (NM_004244),
IL-10 (NM_000572), CCL-22 (NM_002990), TGFbeta1 (NM_000660) and beta-actin
(NM_001101, housekeeping gene) were supplied by Primerdesign (Primerdesign, UK). In
both cultured cell types, gene expression values were calculated using the comparative ΔΔCT
method and they correspond to the expression level (fold increase) of the target gene derived
from each treatment and normalized to that of M0-controls or untreated cells respectively
(taken as unit value by definition) [22]. In all qRT-PCR, the melting curve was performed to
confirm the specificity of the SYBR green assay.
Gel Zymography
The conditioned medium was collected and the total amount of protein quantified by Bradford
method. For every condition, 0.035mg of proteins were separated by electrophoresis on 10%
tris-glycine gel containing gelatin (1mg/mL, Sigma-Aldrich). The gel was washed in PBS1x
and 0.1% triton-X for 1 hour and then incubated overnight at 37˚C in a solution containing
CaCl2 10mM, NaCl 200nM, TRIS 40mM pH7.5. The gel was coloured with 0.2% brilliant blue
(Sigma-Aldrich) in a solution of 50% methanol and 10% acetone and subsequently incubated
in a de-stained solution (50% methanol, 10% acetone). The MMP-9 production was quantified
by UVITEC analysis software (UVITEC).
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After densitometric analysis, in both cultured cell types, the values of each treatment were
normalized to that of M0-controls or untreated cells, respectively (taken as unit value by defi-
nition), obtaining the increased production of MMP-9.
Statistical Analysis
The statistical evaluation was carried out by GraphPad Prism 5 analysis software using the
Mann-Whitney-U non-parametric test. Any p-value lower than 0.05 was considered as statisti-
cally significant. Results were indicated as mean±standard deviation (SD).
Results
Effects of ET-1, ETA/BRA and IL-4 on CD68, CD204 and CD206
Expression in Cultured Macrophages
As observed by immunocytochemistry, in cultured THP-1 the stimulation with PMA induced
cell adhesion and the expression of CD68 (macrophage marker), supporting their differentia-
tion into M0 macrophages (Fig 1).
This result was in accordance with several in vitro studies, indicating THP-1-derived mac-
rophages as a well-characterized model for studying macrophage polarization [16,17,23–25].
In cultured M0 macrophages, ET-1 increased the protein expression of CD204 and CD206
compared to M0-controls after 72 hours of treatment (Fig 1). Of note, the increase in the pro-
tein expression of these M2 phenotype markers induced by ET-1 was contrasted by the action
of ETA/BRA (Fig 1).
The ability of ET-1 to induce M2 polarization was evaluated also in primary cultures of
human monocyte-derived macrophages.
Preliminary results showed that both untreated and treated cells did not express CD68 after
3 days of culture, indicating their incomplete differentiation into macrophages (data not
shown). On the contrary, after 6 days, cultured cells were able to express CD68, confirming
their differentiation into activated macrophages (Fig 2).
Based on these results, in cultured human monocyte-derived macrophages the effects of
ET-1 and ETA/BRA were evaluated at 6 days of treatment.
In these primary cultures, ET-1 induced the increase in the protein expression of CD204
and CD206 compared to untreated cells (Fig 2). Of note, once again ETA/BRA antagonized this
increased expression of both M2 phenotype markers induced by ET-1 (Fig 2).
In both cultured M0 and human monocyte-derived macrophages, IL-4 induced the expres-
sion of CD204 and CD206, confirming its role as an inducer of M2 polarization (Figs 1 and 2).
Effects of ET-1, ETA/BRA and IL-4 on Protein Synthesis of M2
Phenotype Markers in Cultured Macrophages
To confirm the results observed by immunocytochemistry and to determine the increase in
protein synthesis of M2 phenotype markers, Western blotting was performed on both cell
types.
In cultured M0 macrophages, ET-1 induced a significant over-production of CD204,
CD206 and CD163 compared to M0-controls (p<0.05; p<0.01; p<0.05) (Fig 3).
The ability of ET-1 to increase the protein synthesis of these M2 phenotype markers was
found to be similar to that induced by IL-4 (p<0.01 vs. M0-controls, for all proteins) (Fig 3).
Of note, ETA/BRA significantly contrasted the increased protein expression of these M2 mark-
ers (p<0.05 vs ET-1 treated cells for all proteins) (Fig 3).
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In cultured human monocyte-derived macrophages, ET-1 significantly induced the over-
production of CD204, CD206 and CD163 protein synthesis compared to untreated cells
(p<0.01 for all proteins), showing effects similar to those of IL-4 (p<0.01 vs untreated cells,
for all proteins) (Fig 4).
In primary cultures of human monocyte-derived macrophages, the protein synthesis of
TGFbeta1 was also investigated. Of note, ET-1 induced a significant increase in TGFbeta1 syn-
thesis compared to untreated cells (p<0.05) (Fig 4).
In these cells, the ability of ET-1 to induce the protein expression of M2 phenotype markers
was significantly antagonized by ETA/BRA (p<0.01 for CD204; p<0.05 for CD206 and CD163
vs. ET-1 treated cells), which also contrasted the ET-1-induced increase in TGFbeta1 protein
expression (non significantly) (Fig 4).
Fig 1. Evaluation of CD68, CD204 and CD206 expression in cultured THP-1-derived macrophages.
Immunocytochemistry of CD68 (marker of macrophage activation), CD204 and CD206 protein expression in
cultured THP-1-derived macrophages (M0 macrophages) treated for 72 hours with ET-1 (100nM) and IL-4
(10ng/mL) alone, or pre-treated with ETA/BRA (bosentan, 10-5M) for 1 hour before being stimulated with ET-1.
Cultured M0 macrophages maintained for 72 hours in RPMI at 5% of FBS were used as controls (M0-controls).
Immunocytochemistry was performed on four independent in vitro experiments. The detection of protein
expression was performed evaluating the same number of cells by light microscopy (magnification 40X).
doi:10.1371/journal.pone.0166433.g001
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Effects of ET-1, ETA/BRA and IL-4 on the Gene Expression of M2
Phenotype Markers in Cultured Macrophages
In cultured M0 macrophages, ET-1 induced a significant increase in the gene expression of
CD204, CD206 and CD163 compared to M0-controls (p<0.01 for CD204 and CD206; p<0.05
for CD163) (Fig 5).
Moreover, ET-1 significantly induced the over-expression of IL-10 and CCL-22 compared
to M0-controls (p<0.05 for both), showing effects similar to those induced by IL-4 (p<0.05
for CD204, CD163 and IL-10; p<0.01 for CD206 and CCL-22 vs. M0-controls) (Fig 5).
The effects of ET-1 were contrasted by treatment with ETA/BRA, which significantly antago-
nized the increased gene expression of CD204, CD206, CD163, IL-10 and CCL-22 (p<0.05 for
CD204, CD206 and CD163; p<0.01 for IL-10 and CCL-22 vs. ET-1 treated cells) (Fig 5).
Fig 2. Evaluation of CD68, CD204 and CD206 expression in cultured human monocyte-derived
macrophages. Immunocytochemistry of CD68 (marker of macrophage activation), CD204 and CD206
protein expression in cultured human monocyte-derived macrophages treated for 6 days with ET-1 (100nM)
and IL-4 (10ng/mL) alone, or pre-treated with ETA/BRA (bosentan, 10-5M) for 1 hour before being stimulated
with ET-1. Cultured human monocyte-derived macrophages maintained for 6 days in RPMI at 10% of FBS
were used as untreated cells. Immunocytochemistry was performed on four independent in vitro experiments.
The detection of protein expression was performed evaluating the same number of cells by light microscopy
(magnification 40X).
doi:10.1371/journal.pone.0166433.g002
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In primary cultures of monocyte-derived macrophages, ET-1 induced a significant increase
in the gene expression of all the investigated M2 phenotype markers compared to untreated
cells (p<0.05 for CD204, CD163 and IL-10; p<0.01 for CD206 and CCL-22) (Fig 6).
Also in primary cultures, the ability of ET-1 to increase the gene expression of all these M2
phenotype markers was shown to be similar to that determined by IL-4 (p<0.01 for CD204,
CD206; CCL-22; p<0.05 for CD163 and IL-10 vs. untreated cells) (Fig 6).
Fig 3. Evaluation of protein synthesis of M2 phenotype markers in cultured THP-1-derived macrophages. Western blotting and related
densitometric analysis of CD204, CD206 and CD163 protein synthesis in cultured THP-1-derived macrophages (M0 macrophages) treated for 72
hours with ET-1 (100nM) and IL-4 (10ng/mL) alone, or pre-treated with ETA/BRA (bosentan, 10-5M) for 1 hour before being stimulated with ET-1.
Cultured M0 macrophages maintained for 72 hours in RPMI at 5% of FBS were used as controls (M0-controls). Western blotting was performed on six
independent in vitro experiments. The data of CD204, CD206 and CD163 protein synthesis are shown as mean±SD and indicated as increase in
protein synthesis.
doi:10.1371/journal.pone.0166433.g003
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Fig 4. Evaluation of protein synthesis of M2 phenotype markers and TGFbeta1 in cultured human monocyte-derived
macrophages. Western blotting and related densitometric analysis of CD204, CD206, CD163 and TGFbeta1 protein synthesis in cultured
human monocyte-derived macrophages treated for 6 days with ET-1 (100nM) and IL-4 (10ng/mL) alone, or pre-treated with ETA/BRA
(bosentan, 10-5M) for 1 hour before being stimulated with ET-1. Cultured human monocyte-derived macrophages maintained for 6 days in
RPMI at 10% of FBS were used as untreated cells. Western blotting was performed on six independent in vitro experiments. The data of
CD204, CD206, CD163 and TGFbeta1 protein synthesis are shown as mean±SD and indicated as increase in protein synthesis.
doi:10.1371/journal.pone.0166433.g004
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Fig 5. Evaluation of gene expression of M2 macrophage phenotype markers in cultured THP-1-derived macrophages. Quantitative real
time polymerase chain reaction (qRT-PCR) of CD204, CD206, CD163, IL-10 and CCL-22 gene expression in cultured THP-1-derived macrophages
(M0 macrophages) treated for 72 hours with ET-1 (100nM) and IL-4 (10ng/mL) alone, or pre-treated with ETA/BRA (bosentan, 10-5M) for 1 hour
before being stimulated with ET-1. Cultured M0 macrophages maintained for 72 hours in RPMI at 5% of FBS were used as controls (M0-controls).
The qRT-PCR was performed on six independent in vitro experiments and the data of CD204, CD206, CD163, IL-10 and CCL-22 gene expression
are shown as mean±SD and indicated as increase in gene expression.
doi:10.1371/journal.pone.0166433.g005
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Fig 6. Evaluation of gene expression of M2 macrophage phenotype markers and TGFbeta1 in cultured human monocyte-
derived macrophages. Quantitative real time polymerase chain reaction (qRT-PCR) of CD204, CD206, CD163, IL-10, CCL-22 and
TGFbeta1 gene expression in cultured human monocyte-derived macrophages treated for 6 days with ET-1 (100nM) and IL-4 (10ng/mL)
alone, or pre-treated with ETA/BRA (bosentan, 10-5M) for 1 hour before being stimulated with ET-1. Cultured human monocyte-derived
macrophages maintained for 6 days in RPMI at 10% of FBS were used as untreated cells. The qRT-PCR was performed on six
independent in vitro experiments and the data of CD204, CD206, CD163, IL-10, CCL-22 and TGFbeta1 gene expression are shown as
mean±SD and indicated as increase in gene expression.
doi:10.1371/journal.pone.0166433.g006
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In addition, ET-1 significantly up-regulated the gene expression of TGFbeta1 (p<0.05 vs.
untreated cells) (Fig 6).
ETA/BRA significantly antagonized the ET-1-induced increase in the gene expression of M2
phenotype markers in these cultured cells (p<0.05 for CD204, CD206, CD163, IL-10; p<0.01
for CCL-22 vs. ET-1 treated cells) (Fig 6). Moreover, ETA/BRA treatment contrasted the ET-
1-induced up-regulation of TGFbeta1 (non significantly) (Fig 6).
The effects of the combined treatment with ET-1 and IL-4 in inducing the expression of
protein and gene expression of M2 macrophage phenotype markers were investigated and no
synergistic effects on both cultured M0 and human monocyte-derived macrophages were
observed (data not shown).
Effects of ET-1, ETA/BRA and IL-4 on MMP-9 Production in Cultured
Macrophages
In cultured M0 macrophages, ET-1 induced a significant production and release of MMP-9
compared to M0-controls (p<0.05) (Fig 7A).
The increased production of MMP-9 induced by ET-1 was significantly contrasted by treat-
ment with ETA/BRA (p<0.05 vs. ET-1 treated cells) (Fig 7A).
Similar results were observed in primary cultures of human monocyte-derived macro-
phages (Fig 7B). In these cultured cells, ET-1 significantly increased the production and release
of MMP-9 compared to untreated cells (p<0.05) (Fig 7B). The ET-1-mediated increase of
MMP-9 was significantly contrasted by treatment with ETA/BRA (p<0.05 vs. ET-1 treated
cells) (Fig 7B).
Conversely, IL-4 did not induce the over-production of MMP-9 in either cultured M0 mac-
rophages or human monocyte-derived macrophages (Fig 7).
Discussion
The results of the study show, for the first time, that ET-1 induces the over-expression of
CD204, CD206 and CD163 in cultured human macrophages and therefore their transition
into the M2 phenotype.
As known, M2 macrophages, together with the expression of these markers, share an IL-
12low, IL-23low and IL10high phenotype and produce high levels of CCL-22 compared to M1
macrophages, which are IL-12high, IL-23high and IL10low cells [1–3].
The ability of ET-1 to induce the up-regulation of IL-10 and CCL-22 in cultured human
macrophages further suggests its possible action as an inducer of the M2 phenotype. Of note,
the effects of ET-1 in up-regulating all these M2 markers were found contrasted by the block-
age of ETA and ETB receptors through the action of the dual ET receptor antagonist bosentan,
suggesting a possible receptor-dependent mechanism for ET-1 in inducing the M2 phenotype
in cultured human macrophages.
The value of present results lies also in the fact that they were obtained in cultured macro-
phages derived from the differentiation of both THP-1 cells and human circulating monocytes.
As recently discovered, M2 macrophage polarization is involved in the pathogenesis of sev-
eral fibrotic diseases, including pulmonary fibrosis and SSc [9,26]. In idiopathic pulmonary
fibrosis (IPF), the over-expression and activation of CD204 in alveolar macrophages shifted
these cells to a pro-fibrotic M2 phenotype [26]. Moreover, in mouse models of pulmonary fibro-
sis, the blockage of CD204 (by the action of a specific blocking monoclonal antibody) in M2
macrophages was shown to completely abrogate the development of fibrotic process [26–28].
In SSc patients, a significant portion of circulating cells belonging to the monocyte/macro-
phage lineage abnormally differentiates into a CD14brightCD204+CD163+ cell subset. This
Endothelin-1 Effects on Cultured Macrophages
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latter characterizes the immune inflammatory infiltrate of the skin, indicating a possible
contribution of these cells in the pathogenesis of the SSc fibrosis [9,10]. The presence of
CD163+macrophages was also observed in acute and chronic inflammation, in wound healing
sites of SSc patients (with interstitial lung disease) and in a number of pathological conditions,
including pulmonary fibrosis [29–31]. In addition to that, the expression of CD206 was highly
increased in SSc patients with pulmonary arterial hypertension (PAH), correlating with pul-
monary artery pressure and PAH-related mortality [32]. Finally, the CD206+M2 macrophages
Fig 7. Evaluation of pro-fibrotic MMP-9 production in cultured macrophages. Evaluation by gel zymography of MMP-9 production and
related densitometric analysis in cultured M0-macrophages and human monocyte-derived macrophages. (A) Cultured M0 macrophages were
treated for 72 hours with ET-1 (100nM) and IL-4 (10ng/mL) alone, or pre-treated with ETA/BRA (bosentan, 10-5M) for 1 hour before the stimulation
with ET-1. Cultured M0 macrophages maintained for 72 hours in RPMI at 5% of FBS were used as controls (M0-controls). (B) Cultured human
monocyte-derived macrophages treated for 6 days with ET-1 (100nM) and IL-4 (10ng/mL) alone, or pre-treated with ETA/BRA (10-5M) for 1 hour
before the stimulation with ET-1. Cultured human monocyte-derived macrophages maintained for 6 days in RPMI at 10% of FBS were used as
untreated cells. Gel zymography was performed on six independent in vitro experiments and the data of MMP-9 production are shown as mean
±SD.
doi:10.1371/journal.pone.0166433.g007
Endothelin-1 Effects on Cultured Macrophages
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may trigger the activation of fibroblasts through the over-production of IL-10 and CCL-22,
contributing to the fibrotic progression in patients with IPF [31,33].
The results of the study show that the ET-1-induced M2 polarization seems to be similar to
that mediated by IL-4, which represents an important M2 inducer [1–4].
As known, IL-4 induces macrophages to polarize primarily into the M2a phenotype, which
is involved in the scar tissue formation in both wound healing and fibrosis [34]. Moreover,
M2a macrophages are found in several diseases characterized by an extensive fibrosis [35,36].
Interestingly, increased serum levels of IL-4 have been detected in SSc patients, suggesting
how this cytokine, by activating of M2 macrophages, might be involved in the pathogenesis of
the disease [33,37].
The ability of ETA/BRA to contrast the induction of the M2 phenotype might contribute to
attenuate ET-1 effects in those diseases characterized by extensive fibrosis and macrophage
infiltrate, such as SSc.
The presence of M2 macrophages was also observed in cancer tissues and correlates with
a more malignant phenotype characterized by a higher tumour invasion, the presence of
lymph node metastasis and a poor prognosis [38–40]. These cells are called tumour associ-
ated macrophages (TAMs) and are characterized by the expression of CD204, CD206,
CD163 [41]. TAMs also express high levels of IL-10 and CCL-22, which are necessary for the
recruitment of T-regulatory cells to the tumour site to maintain an immunosuppressive
microenvironment [41–43]
Another important feature of M2 macrophages is to be a major source of pro-fibrotic
TGFbeta1 as well as MMP-9, contributing both directly and indirectly to fibrotic processes in
several diseases, including IPF and SSc [1,3,8,44].
In primary cultures of human monocyte-derived macrophages, the observed ability of ET-1
to significantly increase both gene and protein expression of TGFbeta1 and, unlike to IL-4,
MMP-9 production might suggest its possible involvement in establishing the formation of a
fibrotic environment.
As known, TGFbeta1 and MMP-9 are primarily produced by TAMs compared to the other
macrophage phenotypes and seem to be necessary to promote the migration and invasion of
tumour cells [45]. In addition, TGFbeta1 is responsible for the transition of endothelial and
epithelial cells as well as fibroblasts into myofibroblasts, therefore further contributing to fibro-
sis [13,46].
Macrophage-released MMP-9 contributes to fibrosis by inducing the activation of myofi-
broblasts, playing an important role in the pathogenesis of diseases characterized by an
inflammatory etiology and extracellular matrix remodelling that requires selected therapies
[44,47–51].
The ability of ETA/BRA (bosentan) to contrast these ET-1 effects might be important pri-
marily in those fibrotic diseases characterized by high circulating levels of ET-1 and by the
presence of macrophage infiltrate, as observed in SSc and type 2 diabetes [11,12].
Since this study primarily analysed M2 markers (i.e. CD204, CD206, CD163 and IL-10)
and molecules related to a fibrotic phenotype (i.e. CCL-22, TGFbeta1 and MMP-9), the evalua-
tion of other cytokines and chemokines (i.e. IL-12, CCL-2, CCL-17, CCL-18) produced by M2
macrophages will be necessary, in order to better characterize the ET-1-induced M2 phenotype
compared to other M2 sub-populations (i.e. M2b, M2c). At the same time, the intracellular sig-
nalling pathways responsible for the M2 polarization mediated by ET-1 should be investigated.
A limitation of the present research is that only the effects of a dual ETA/BRA, which acts on
both ETA and ETB receptors, was investigated. Further experiments evaluating the blockage of
ETA and ETB receptor singularly, through the action of a selective ETA or ETB receptor antago-
nist, should be done.
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In conclusion, macrophages might appear to be a possible further cellular mediator of ET-1
effects through their transition into a “pro-fibrotic” M2 phenotype, which seems to share fea-
tures and properties with M2a and TAM sub-populations.
Supporting Information
S1 Fig. Evaluation of the time-dependent effects of ET-1 on the gene expression of M2
macrophage phenotype markers in cultured THP-1-derived macrophages. Quantitative
real time polymerase chain reaction (qRT-PCR) of CD204, CD206 and CD163 gene expression
in cultured THP-1-derived macrophages (M0 macrophages) treated for 24, 48 and 72 hours
with ET-1 (100nM). Cultured M0 macrophages maintained for 24, 48 and 72 hours in RPMI
at 5% of FBS were used as controls (M0-controls). The qRT-PCR was performed on four inde-
pendent in vitro experiments and the data of CD204, CD206 and CD163 gene expression are
shown as mean±SD and indicated as increase in gene expression.
(TIF)
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